Neutralizing HIV Antibodies

Several methods have been utilized to isolate and characterize individual antibodies from the human repertoire and each of these methods has been applied to the generation of broadly neutralizing HIV antibodies. Discover the latest research on neutralizing HIV antibodies.

June 11, 2020
Open Access

Structural basis of broad HIV neutralization by a vaccine-induced cow antibody

Science Advances
Robyn L StanfieldVaughn V Smider
June 17, 2020

Usability of a Consumer Health Informatics Tool Following Completion of a Clinical Trial: Focus Group Study

Journal of Medical Internet Research
Hwayoung ChoRebecca Schnall
June 25, 2020
Open Access

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses

BioRxiv : the Preprint Server for Biology
Fabian SchmidtPaul D Bieniasz
June 12, 2020

IgA Summons IgG to Take a Hit at HIV-1

Cell Host & Microbe
Giuliana Magri, Andrea Cerutti
July 2, 2020
Open Access

Pre-S Deletions are Predominant Quasispecies in HIV/HBV Infection: Quasispecies Perspective

Infection and Drug Resistance
Yuan NieFeng-Yu Hu
June 11, 2020

Fever of unknown origin: evaluation of 110 classical and HIV-associated cases in the last decade

Hospital Practice
Şemsi Nur Karabela, Kadriye Kart Yasar
July 8, 2020

HIV and SARS CoV-2 co-infection: A retrospective, record based, case series from South India

Journal of Medical Virology
Janakiram MarimuthuP Aravind Gandhi
July 9, 2020
Open Access

A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodies

BioRxiv : the Preprint Server for Biology
P. AcharyaBarton F Haynes
July 7, 2020
Open Access

Chitosan-Based Delivery of Avian Reovirus Fusogenic Protein p10 Gene: In Vitro and In Vivo Studies towards a New Vaccine against Melanoma

BioMed Research International
Claudia Robles-PlanellsClaudio Acuña Castillo

Sign up to follow this feed and discover related papers.

Related Feeds

AIDS Malignancies

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/neutralizing-hiv-antibodies/92bc9848-bca9-4f61-bd91-50c851d4bf25